First Quality Home Care Inc | |
8700 W Flagler St Ste 200, Miami, Florida 33174 | |
(305) 223-0150 | |
Not Available |
Name | First Quality Home Care Inc |
---|---|
Location | 8700 W Flagler St Ste 200, Miami, Florida |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Home Health Aide |
Medicare ID | 107617 |
Ownership Type | Proprietary |
Service Area Zip Codes | 33010, 33012, 33013, 33055, 33126, 33134, 33142, 33144, 33172, 33174, 33175, 33184 |
NPI Number | 1295791887 |
Organization Name | FIRST QUALITY HOME CARE , INC |
Address | 9250 W Flagler St Ste 510, Miami, FL 33174 |
Phone Number | 305-223-0150 |
News Archive
Ovarian cancer is often detected at a late stage and it is the leading cause of death due to gynecological cancers, and the sixth leading cause of cancer death in women. According to latest discovery by researchers at Sydney's Garvan Institute there may be a way this killer cancer is detected earlier.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.
Obesity, already a global epidemic, is on the rise. Over one-third of the U.S. population is currently afflicted, according to the Centers for Disease Control and the monetary costs alone are approaching $150 billion dollars annually.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 7 days ago
Quality Rating: | Not Available* |
* The number of patient episodes for this measure is too small to report. |
News Archive
Ovarian cancer is often detected at a late stage and it is the leading cause of death due to gynecological cancers, and the sixth leading cause of cancer death in women. According to latest discovery by researchers at Sydney's Garvan Institute there may be a way this killer cancer is detected earlier.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.
Obesity, already a global epidemic, is on the rise. Over one-third of the U.S. population is currently afflicted, according to the Centers for Disease Control and the monetary costs alone are approaching $150 billion dollars annually.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 7 days ago
News Archive
Ovarian cancer is often detected at a late stage and it is the leading cause of death due to gynecological cancers, and the sixth leading cause of cancer death in women. According to latest discovery by researchers at Sydney's Garvan Institute there may be a way this killer cancer is detected earlier.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its drug candidate bafetinib (formerly known as INNO-406) demonstrated statistically significant inhibition of glioblastoma multiforme cell lines in a preclinical trial. Glioblastoma multiforme is the most common and aggressive primary adult brain tumor.
When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.
Obesity, already a global epidemic, is on the rise. Over one-third of the U.S. population is currently afflicted, according to the Centers for Disease Control and the monetary costs alone are approaching $150 billion dollars annually.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
› Verified 7 days ago
New Sky Home Health Care Corp Location: 7235 Sw 24 St Ste 204, Miami, Florida 33155 Ratings: NA Phone: (305) 558-6454 | |
E & R Health Care Inc Location: 3955 Sw 137th Avenue Ste 5, Miami, Florida 33175 Ratings: Phone: (305) 468-9544 | |
Cruz Healthcare Corp Location: 10300 Sunset Drive Ste 444, Miami, Florida 33173 Ratings: Phone: (305) 221-9981 | |
Alleanza Health Care Associates Llc Location: 15190 Sw 136th Street Suite 32, Miami, Florida 33196 Ratings: Phone: (305) 238-1441 | |
American Providers, Inc. Location: 2000 Nw 89th Pl, Miami, Florida 33172 Ratings: Phone: (305) 591-9975 | |
Baptist Health Home Care Location: 12400 Sw 127 Ave, Miami, Florida 33186 Ratings: Phone: (786) 596-3010 |